Generics 6

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Isoproterenol hydrochloride manufacturers

6 products found

Filters

6 products found

isoproterenol hydrochloride

Injection 1 mg/5 ml

Dossier type
CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Manufacturer #15176

Manufacturer usually replies in 5 days

isoproterenol hydrochloride

Vials, injection 2 mg/1 ml; 1 mg/5 ml - 5ml

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA, EU GMP
Unavailable markets
United States
Registered in
United States
Available for
Distribution only
Manufacturer #27050
This US-based pharmaceutical manufacturer specializes in generic and specialty injectable drugs, focusing on fulfilling critical medical needs. Their product pipeline includes first-to-market FDA-approved generics across several therapeutic areas, such as cardiovascular, oncology, antispasmodic, and anti-epileptic. They primarily produce prescription medications in dosage forms like injections and adhere to strict GMP certifications. The company emphasizes quality control throughout its supply chain and boasts a strong commitment to employee well-being and continuous improvement. While their focus is on injectables, they are expanding into other areas like ophthalmic solutions with recent FDA approvals for generic fluorescein injection.

isoproterenol hydrochloride

Vials, injection 0.2 mg/ml - 1 ml, 5 ml

Dossier type
US CTD
Dossier status
Under development
Country of origin
India
GMP approvals
FDA
Comments
ANDA/R &D Status: ANDA to be filed in Q3-2023, approval expected Q3-2024; US RLD / Holder: "Isuprel/Bausch Health US"; Indication: Nonselective beta-adrenergic agonist with very low affinity for alpha-adrenergic receptors.
Manufacturer #8216
This fast-growing pharmaceutical company boasts a dominant presence in Latin America, Francophone Africa, and a growing footprint in regulated markets like the EU and North America. Founded in 1990, it initially focused on ointments and creams before expanding its product range significantly. With over 4,000 global product licenses, they cater primarily to the "Bottom of the Pyramid" through their owned distribution networks. The company's manufacturing facility holds multiple certifications including US FDA approval (with three successful inspections since 2016), EU-GMP, ANVISA-Brazil, INVIMA-Colombia, and COFEPRIS-Mexico. They prioritize innovation with a significant portion of their earnings invested in research and development of safe and effective products across various dosage forms. Key therapy areas are not specified.

Manufacturer usually replies in 6 days

Want to see all 6 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible